Investegate |Infant Bacterial Therapeutics Announcements | Infant Bacterial Therapeutics: Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams
Infant Bacterial Therapeutics Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams A l ment criteria of The Connection Study to include 500 - 1000 gram birth weight premature infants. The Data Monitoring Committee (DMC) has performed a per protocol predefined safety and tolerability assessment of the first 300 patients...
Daniel Mackey Data Monitoring Committee Infant Bacterial Therapeutics Connection Study Staffan Str Chief Executive Officer
Source: investegate.co.uk